Suchergebnisse - "Strasser, Michael"

PubPharm (7)

1

DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting

enthalten in: Transplant international : official journal of the European Society for Organ Transplantation | 2016

von Beinhardt, S. | Al Zoairy, R. | Ferenci, P. | +12

2

Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2014

von Stättermayer, A. | Rutter, K. | Beinhardt, S. | +7

3

A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection

enthalten in: Journal of hepatology | 2013

von Beinhardt, S. | Payer, B. | Datz, C. | +13

4

Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection

enthalten in: Gastroenterology | 2012

von Beinhardt, S. | Aberle, J. | Strasser, M. | +16

5

Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response

enthalten in: Gastroenterology | 2010

von Ferenci, P. | Laferl, H. | Scherzer, T. | +68

ReprintIn: Korean J Hepatol. 2010 Jun;16(2):201-5. - PMID 20606507

6

Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response

enthalten in: Gastroenterology | 2008

von Ferenci, P. | Laferl, H. | Scherzer, T. | +66

7

A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3

enthalten in: Hepatology (Baltimore, Md.) | 2008

von Ferenci, P. | Brunner, H. | Laferl, H. | +68

CommentIn: Hepatology. 2009 Apr;49(4):1395-6; author reply 1396. - PMID 19330867

1
[1]